Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 13,065 shares at $35.41 ($463K) on 2017-08-08, disclosed to the SEC on 2017-08-09.
Scheduled sale ($463k) by SVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |